Cary Danis Lowe Archives - Carey Danis & Lowe

Chicago Tribune Article on Testosterone

By | Pharmaceutical litigation, Testosterone, Uncategorized

testosterone gel lawsuitTestosterone therapy promises men more energy and heightened libidos, but some patients say those promises were accompanied by heart attacks and pulmonary embolisms.

Testosterone has been approved for men impacted by testicular injury, genetic conditions or chemotherapy. However, due to a huge marketing campaign to doctors and patients, testosterone has become a $200 billion a year industry, touting the “Fountain of Youth” effects of increased energy and a re-charged sex drive.

About a week after receiving his first testosterone injection Steve Schabel, of Indiana, had difficulty breathing, which got worse over time. At the hospital he learned he’d suffered a near-fatal double pulmonary embolism, blocking veins on both lungs.

He felt like he was going to die. Now he’s taking blood thinners for the rest of his life.

AbbVie and Abbott Laboratories, both located in North Chicago, make testosterone. They and other drug companies are defendants in the 2,000 lawsuits brought by men who have suffered heart attacks and strokes that they claim were caused by testosterone therapy.

Many of the lawsuits have been combined into one Chicago courtroom that may help determine the future of the off-label medical treatment. The lawsuits raise questions on how the drug is marketed and highlight patient difficulty in assessing benefits and risks.

Carey Danis & Lowe can help victims of testosterone therapy.

If you believe that testosterone therapy is to blame for your heart attack or stroke, call Cary Danis & Lowe attorneys for a free legal consultation. You may be eligible for compensation.

We work alongside a team of medical professionals and our nurses are available to answer your health questions.

Contact us by phone at 800.721.2519, or complete a confidential personal injury claim form.

Phone Call Scams Directed at Transvaginal Mesh Injuries

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsScammers are asking women to lie about complications from transvaginal mesh surgeries, hinting at potentially large compensation sums.

These phone scammers ask if women have had the mesh operation and if they haven’t, they’re asked to lie and say that they’ve had the transvaginal mesh implanted. Scammers may be trying to glean private information from their targets.

Unfortunately, this scam shows that knowledge of transvaginal mesh complications has become “mainstream.” Numerous television ads also entice viewers to call a phone number if they’ve suffered mesh injuries.

If you’ve been harmed by transvaginal mesh, you can trust the attorneys at Carey Danis and Lowe to get you justice.

Cary Danis & Lowe has extensive medical device liability experience.

Pelvic injuries or other damage from transvaginal mesh can be a lifelong challenge. Our product liability lawyers will provide expert legal counsel to assist you in the process of getting the justice you deserve.

Please contact us online or give us a call at 800-721-2519. We’ll help you fight medical device corporate wrongdoing.

Despite Current Safety Concerns, FDA Approves Newest Pelvic Mesh Product

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsThe US FDA approved Caldera Medical’s latest version of Vertessa Lite mesh in June 2015, even though there is ongoing controversy about the safety of these type of devices.

Caldera Medical, a startup, makes the product to treat Pelvic Organ Prolapse (POP). The large pore mesh corrects the position of vagina after pelvic organs have bulged into the top of the vagina.

On the flip side of this approval is the fact that another mesh manufacturer, Medtronic, recently paid a huge settlement for more than 11,000 vaginal mesh victims.

The FDA has known since 2011 that dire problems result from transvaginal repair for Pelvic Organ Prolapse.

Indeed, they are considering reclassifying pelvic mesh from a moderate risk or class II device, to the more stringent class III device which necessitates a premarket approval (PMA) application.

The premarket approval application will require manufacturers to provide clinical data to show a reasonable assurance of safety and effectiveness for transvaginal mesh used in POP repair.

Unfortunately, with the recent approval of the updated mesh product, Caldera Medical hasn’t been subject to these more stringent testing procedures. The company is one of many named in more than 70,000 lawsuits regarding transvaginal mesh.

The FDA says that the most common problems with these mesh products are erosion through vaginal epithelium, infection, pain, urinary problems and recurrence of prolapse and/or incontinence.

Cary Danis & Lowe will fight pharmaceutical companies on your behalf.

Our attorneys represent women who have suffered emotionally and physically from defective transvaginal mesh. We continue to research cases and are available to discuss your case during a free case evaluation.

Please contact Carey Danis & Lowe by phone at 800.721.2519 or by completing a confidential personal injury claim form.